Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NeoGluCO neonatal hypoglycaemia trial
ACTRN12620000129987Phase 3Completed
- Sponsor
- The University of Auckland
- Start
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Neonatal hypoglycemia comparing Diazoxide with Placebo (2 arms). Primary endpoint: Primary outcome: time to resolution of hypoglycaemia. Started May 2020; status: completed.
02
Drugs
diazoxide
03
Conditions
Neonatal hypoglycemia
Beyond the preview
Go deeper on ACTRN12620000129987.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12620000129987.